Renal Ewing sarcoma with extensive neuroectodermal differentiation: Case report and literature review

1 Javery O, Krajewski K, O’Regan K, Kis B, Giardino A, Jagannathan J et al. A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. AJR Am J Roentgenol. 2011;197:W1015-22. Search in Google Scholar

2 Enrique de Alava, Gerald WL. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 2000; 18:204-13. Search in Google Scholar

3 Pandey, R., Batra, R., Dhaigude, P. et al. Primitive neuroectodermal tumor of the kidney: a rare case. Afr J Urol 2021; 27:45. Search in Google Scholar

4 Ekram T, Elsayes KM, Cohan RH, Francis IR. Computed tomography and magnetic resonance features of renal Ewing sarcoma. Acta Radiol. 2008; 49:1085-90. Search in Google Scholar

5 Li J, Nie F, Li Y. Extraosseous Ewing’s sarcoma/peripheral primitive neuroectodermal tumour of the kidney: a case report and literature review. BMC Urol. 2022; 22:197. Search in Google Scholar

6 Zhang S, Li Y, Wang R, Song B. Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a case report and literature review. Transl Androl Urol. 2019; 8:562-566. Search in Google Scholar

7 Angel JR, Alfred A, Sakhuja A, Sells RE, Zechlinski JJ. Ewing’s sarcoma of the kidney. Int J Clin Oncol. 2010; 15:314-8. Search in Google Scholar

8 Risi E, Iacovelli R, Altavilla A, Alesini D, Palazzo A, Mosillo C et al. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney. Urology. 2013; 82:382-6. Search in Google Scholar

9 Thyavihally YB, Tongaonkar HB, Gupta S, Kurkure PA, Amare P, Muckaden MA et al. Primitive neuroectodermal tumor of the kidney: a single institute series of 16 patients. Urology. 2008; 71:292-6. Search in Google Scholar

10 Liang L, Song H, Ma B, Zhang Z, Zhu K, Li Q, et al. Renal Ewing’s sarcoma/primitive neuroectodermal tumor (PNET): a case series of 7 patients and literature review. Transl Androl Urol. 2021; 10 :548-554. Search in Google Scholar

11 Sadiq M, Ahmad I, Shuja J, Ahmad K. Primary Ewing sarcoma of the kidney: a case report and treatment review. CEN Case Rep. 2017; 6:132-135. Search in Google Scholar

12 Niederhuber JE, Armitage JO et al. Abeloff’s Clinical Oncology. 6th Edition. Elsevier. 2020; 90: 1655-1692. Search in Google Scholar

13 Nazemi A, Daneshmand S. Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival. Urol Oncol. 2020;38:334-343. Search in Google Scholar

14 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-4. Search in Google Scholar

15 Rowe RG, Thomas DG, Schuetze SM, Hafez KS, Lawlor ER, Chugh R. Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors. Urology. 2013; 81:347-53. Search in Google Scholar

16 Chen H., Li, Y., Zeng, Q., & Wu, G. Renal primitive neuroectodermal tumor: A rare case with a good prognosis. Front. Surg. 2023. Search in Google Scholar

17 Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies. Urology. 2006; 68:257-62. Search in Google Scholar

18 Parada D, Godoy A, Liuzzi F, Pelia KB, Romero A, Parada AM. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney. An infrequent finding. Arch Esp Urol. 2007; 60:321-5. Search in Google Scholar

19 Patra S, Trivedi P. Primary Ewing sarcoma of the kidney: A series of four cases. Malays J Pathol. 2022; 44:93-99. Search in Google Scholar

20 Ellison, D. A., Parham, D. M., Bridge, J., & Beckwith, J. B. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: A potential source of confusion?: A study of 30 cases from the National Wilms Tumor Study Pathology Center. Human Pathology. 2007; 38: 205-211. Search in Google Scholar

21 Mangray S, Kelly DR, LeGuellec S, Fridman E, Aggarwal S, Shago M et al. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis. Am J Surg Pathol. 2018; 42:1360-1369. Search in Google Scholar

22 Italiano A, Sung YS, Zhang L, Singer S, Maki RG, Coindre JM et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012; 51: 207:18. Search in Google Scholar

23 WHO Classification of Tumors Editorial Board. Soft Tissue and Bone Tumours 5th Edition. 2020; 2:321-333. Search in Google Scholar

24 Yang J, Xu Y, Chen Y, Li T, Zhang X, Hu T et al. Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. Cancer Biol Med. 2022; 19:1496–502. Search in Google Scholar

25 Sanfilippo R. Trabectedin in advanced retroperitoneal well differentiated/dedifferentiated liposarcoma and leiomyosarcoma (TRAVELL): results of a phase 2 study from Italian sarcoma group (ISG). J Clin Oncol. 2022; 40: 11575 Search in Google Scholar

26 Van Tine BA. A phase 1b study of unesbulin (PTC596) plus dacarbazine for the treatment of patients with locally recurrent, unresectable, or metastatic relapsed/refractory leiomyosarcoma. J Clin Oncol. 2022; 40: 11507. Search in Google Scholar

27 Liu X, Xu J, Li F, Liao Z, Ren Z, Zhu L, et al. Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese Cohort Data from NCT03121846. Biomed Pharmacother. 2020; 122: 109587 Search in Google Scholar

28 Chen TW-W. A phase Ib/II study of the combination of lenvatinib (L) and eribulin (E) in advanced liposarcoma (LPS) and leiomyosarcoma (LMS) (LEADER): efficacy updates. J Clin Oncol. 2022; 40: 11506. Search in Google Scholar